Skip to content

Study · Non-randomized trial · n = 71 · 1995

2 results

Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis.

Bradbury MG, Meadow SR

Acta paediatrica (Oslo, Norway : 1992)1 Sept 1995Cited by 46 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with nocturnal enuresis, desmopressin plus alarm produced 6.3 dry nights weekly versus 4.8 with alarm alone, a significant difference.

    In plain wordsIn children with nocturnal enuresis, desmopressin plus alarm increased dry nights compared with alarm alone.

    Outcome
    IncreaseDry nights per week
    Study

    n = 71

    Comparator
    Enuresis alarm alone
    Outcome group
    Urinary continence and bladder function · Kidney and urinary
    Studied dose
    40 micrograms · intranasal · up to 6 weeksAs given in this study (human).

    Measurements

    Mean dry nights per week
    6.3 nights per week
    alarm and desmopressin group
    Mean dry nights per week
    4.8 nights per week
    alarm group

    Source sentences

    Summary
    At the end of treatment there was a significant difference in the mean number of dry nights per week between the two groups (6.3 in the alarm and desmopressin group and 4.8 in the alarm group) and also in the number of children becoming reliably dry.
    4 context sentences
    Summary · context
    Seventy-one children with nocturnal enuresis were enrolled in a controlled trial.
    Summary · context
    The children were allocated to two matched groups.
    Summary · context
    Children in both groups used an enuresis alarm until the end of treatment.
    Summary · context
    Children in the first group were treated with 40 micrograms of intranasal desmopressin (Desmospray) for up to 6 weeks at the start of treatment with the alarm.
  2. 02HumanNon-randomized trialEfficacy outcome

    In children with nocturnal enuresis, more became reliably dry with desmopressin plus alarm than alarm alone, with a significant difference.

    In plain wordsIn children with nocturnal enuresis, more became reliably dry with desmopressin plus alarm than alarm alone.

    Outcome
    IncreaseChildren becoming reliably dry
    Study

    n = 71

    Comparator
    Enuresis alarm alone
    Outcome group
    Urinary continence and bladder function · Kidney and urinary
    Studied dose
    40 micrograms · intranasal · up to 6 weeksAs given in this study (human).

    Source sentences

    Summary
    At the end of treatment there was a significant difference in the mean number of dry nights per week between the two groups (6.3 in the alarm and desmopressin group and 4.8 in the alarm group) and also in the number of children becoming reliably dry.
    4 context sentences
    Summary · context
    Seventy-one children with nocturnal enuresis were enrolled in a controlled trial.
    Summary · context
    The children were allocated to two matched groups.
    Summary · context
    Children in both groups used an enuresis alarm until the end of treatment.
    Summary · context
    Children in the first group were treated with 40 micrograms of intranasal desmopressin (Desmospray) for up to 6 weeks at the start of treatment with the alarm.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.